Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer
1 other identifier
interventional
565
1 country
1
Brief Summary
Rationale Axillary surgery is still fundamental part of breast cancer (BC) management for adjuvant treatment planning. Purpose Randomized phase III trial to compare the effectiveness of surgical therapy with or without axillary dissection following conservative treatment in women with stage I breast cancer. To determine the possibility to avoid axillary surgery in patients with early breast cancer, finding an alternative method to define the need of adjuvant treatment without compromising long-term disease control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started May 1998
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 1998
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2003
CompletedFirst Submitted
Initial submission to the registry
December 15, 2011
CompletedFirst Posted
Study publicly available on registry
January 12, 2012
CompletedJanuary 12, 2012
January 1, 2012
5 years
December 15, 2011
January 9, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in breast cancer mortality and overall survival between the two arms
median follow-up time: 10 years
Study Arms (2)
Arm 1: breast surgery with axillary lymphnodes removal
EXPERIMENTALArm 2: breast surgery without axillary lymphnodes removal
EXPERIMENTALInterventions
Conservative breast surgery with or without axillary dissection
Eligibility Criteria
You may qualify if:
- women with T1N0M0 invasive breast cancer
- years
You may not qualify if:
- bilateral breast cancer
- no other prior or concurrent malignancy except basal cell carcinoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, 20133, Italy
Related Publications (1)
Agresti R, Sandri M, Capri G, Bianchi G, Triulzi T, Lozza L, Trecate G, Trapani A, Ferraris C, Paolini B, Menard S, Greco M, Folli S, Tagliabue E. Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial. Br J Surg. 2025 Mar 4;112(3):znae311. doi: 10.1093/bjs/znae311.
PMID: 40042985DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto Agresti, MD
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 15, 2011
First Posted
January 12, 2012
Study Start
May 1, 1998
Primary Completion
May 1, 2003
Study Completion
May 1, 2003
Last Updated
January 12, 2012
Record last verified: 2012-01